Genmab A/S (NASDAQ:GMAB) Receives $41.60 Average PT from Analysts
Shares of Genmab A/S (NASDAQ:GMAB – Get Free Report) have been assigned a consensus recommendation of “Hold” from the fifteen ratings firms that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the […]
More Stories
Stratos Investment Management LLC Buys 1,088 Shares of Honeywell International Inc. (NASDAQ:HON)
Stratos Investment Management LLC lifted its stake in shares of Honeywell International Inc. (NASDAQ:HON – Free Report) by 6.3% during...
Stratos Investment Management LLC Raises Position in Citigroup Inc. (NYSE:C)
Stratos Investment Management LLC lifted its stake in Citigroup Inc. (NYSE:C – Free Report) by 98.9% in the 3rd quarter,...
Direxion Auspice Broad Commodity Strategy ETF (NYSEARCA:COM) Shares Sold by Stratos Investment Management LLC
Stratos Investment Management LLC cut its stake in Direxion Auspice Broad Commodity Strategy ETF (NYSEARCA:COM – Free Report) by 17.8%...
NuScale Power Co. (NYSE:SMR) Insider Robert K. Temple Sells 115,866 Shares of Stock
NuScale Power Co. (NYSE:SMR – Get Free Report) insider Robert K. Temple sold 115,866 shares of the company’s stock in...
Crown (NYSE:CCK) Upgraded at StockNews.com
StockNews.com upgraded shares of Crown (NYSE:CCK – Free Report) from a hold rating to a buy rating in a research...
FB Financial (NYSE:FBK) Price Target Raised to $50.00
FB Financial (NYSE:FBK – Free Report) had its target price upped by Keefe, Bruyette & Woods from $48.00 to $50.00...